• Jobs
  • Startups
  • Hire
LoginSign up

Pathos

Pathos has 6 open roles, 1 posted in the last 30 days. Stated pay range: $100k – $250k a year. Funding stage: Series D. Last round: $365M, May 15, 2025.

Open roles

  • Pathos logo
    Senior Financial Analyst, Clinical Finance

    Pathos

    • New York, NY
    • On-site · Mid-level
    • $100k–$120k
    AI-native
    Rippling
    Posted 14d ago
  • Pathos logo
    Director, Clinical Operations Program Lead

    Pathos

    • New York, NY
    • On-site · Director / Executive
    • $180k–$220k
    AI-native
    Rippling
    Posted 56d ago
  • Pathos logo
    Staff Software / AI Engineer

    Pathos

    • New York, NY
    • On-site · Staff / Lead
    • $180k–$200k
    Zero to oneAI-native
    Rippling
    Posted 66d ago
  • Pathos logo
    DevSecOps Engineer

    Pathos

    • New York, NY
    • On-site · Senior
    • $180k–$200k
    AI-native
    Rippling
    Posted 93d ago
  • Pathos logo
    Director, CMC – Small Molecule Chemistry

    Pathos

    • New York, NY
    • On-site · Director / Executive
    • $210k–$250k
    Rippling
    Posted 95d ago
  • Pathos logo
    Director, Clinical Science

    Pathos

    • New York, NY
    • On-site · Director / Executive
    • $200k–$240k
    AI-native
    Rippling
    Posted 148d ago

About

Pathos logo

Pathos

AI-enabled drug development built for patients

Pathos is a clinical-stage, AI-enabled precision oncology biotech. We’re building the next generation of biopharma, where drug development is driven by AI and Multimodal patient data, not guesswork. With the largest Multimodal Foundation Model in Oncology as a backbone, we're running an integrated engine that pairs model-driven hypotheses with biological validation and biomarker-driven clinical execution, so the right therapies reach the right patients sooner.

Private companySeries DIn the news
Founded2022
HQNew York City, United States
Size11–50 employees
Unlock human wisdom
ThesisTermsPrivacy
Industry
Biotechnology Research
Funding
  • Series D · $365M · May 15, 2025
News
  • David Pesántez: Proud to Join Pathos AI as Medical Director of Clinical Development
  • AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
  • BMS leads Pathos AI's $237M series E alongside Alzheimer's link-up

Claim pathos.com

Work at pathos.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.